Drugs@FDA document
INTRALIPID 20% Letter · NDA 018449 SUPPL-49
Drugs@FDA document · FRESENIUS · May 4, 2022
Key facts
| Drug name | INTRALIPID 20% |
|---|---|
| Document type | Letter |
| Application | NDA018449 |
| Submission | SUPPL-49 |
| Company | FRESENIUS |
| Document date | May 4, 2022 |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: